Jon Sponheim
Position: MD, PhD
Phone: +47 23 07 24 69
Email:
 

Author network for Jon Sponheim by COREMINE medical


Publications 2017

Server A, Bargalló N, Fløisand Y, Sponheim J, Graus F, Hald JK (2017)
Imaging spectrum of central nervous system complications of hematopoietic stem cell and solid organ transplantation
Neuroradiology, 59 (2), 105-126
PubMed 28255902

Publications 2015

Schrumpf E, Tan C, Karlsen TH, Sponheim J, Björkström NK, Sundnes O, Alfsnes K, Kaser A, Jefferson DM, Ueno Y, Eide TJ, Haraldsen G, Zeissig S, Exley MA, Blumberg RS, Melum E (2015)
The biliary epithelium presents antigens to and activates natural killer T cells
Hepatology, 62 (4), 1249-59
PubMed 25855031

Sundnes O, Pietka W, Loos T, Sponheim J, Rankin AL, Pflanz S, Bertelsen V, Sitek JC, Hol J, Haraldsen G, Khnykin D (2015)
Epidermal Expression and Regulation of Interleukin-33 during Homeostasis and Inflammation: Strong Species Differences
J Invest Dermatol, 135 (7), 1771-1780
PubMed 25739051

Publications 2014

Eskeland SL, Dalén E, Sponheim J, Lind E, Brunborg C, de Lange T (2014)
European panel on the appropriateness of gastrointestinal endoscopy II guidelines help in selecting and prioritizing patients referred to colonoscopy--a quality control study
Scand J Gastroenterol, 49 (4), 492-500
PubMed 24597781

Publications 2012

Pollheimer J, Bodin J, Sundnes O, Edelmann RJ, Skånland SS, Sponheim J, Brox MJ, Sundlisaeter E, Loos T, Vatn M, Kasprzycka M, Wang J, Küchler AM, Taskén K, Haraldsen G, Hol J (2012)
Interleukin-33 drives a proinflammatory endothelial activation that selectively targets nonquiescent cells
Arterioscler Thromb Vasc Biol, 33 (2), e47-55
PubMed 23162017

Sundlisaeter E, Edelmann RJ, Hol J, Sponheim J, Küchler AM, Weiss M, Udalova IA, Midwood KS, Kasprzycka M, Haraldsen G (2012)
The alarmin IL-33 is a notch target in quiescent endothelial cells
Am J Pathol, 181 (3), 1099-111
PubMed 22809957

Publications 2011

Ricanek P, Brackmann S, Perminow G, Lyckander LG, Sponheim J, Holme O, Høie O, Rydning A, Vatn MH, IBSEN II Study Group (2011)
Evaluation of disease activity in IBD at the time of diagnosis by the use of clinical, biochemical, and fecal markers
Scand J Gastroenterol, 46 (9), 1081-91
PubMed 21619483

Publications 2010

Sponheim J, Pollheimer J, Olsen T, Balogh J, Hammarström C, Loos T, Kasprzycka M, Sørensen DR, Nilsen HR, Küchler AM, Vatn MH, Haraldsen G (2010)
Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts
Am J Pathol, 177 (6), 2804-15
PubMed 21037074

Publications 2009

Haraldsen G, Balogh J, Pollheimer J, Sponheim J, Küchler AM (2009)
Interleukin-33 - cytokine of dual function or novel alarmin?
Trends Immunol, 30 (5), 227-33
PubMed 19359217

Publications 2008

Küchler AM, Pollheimer J, Balogh J, Sponheim J, Manley L, Sorensen DR, De Angelis PM, Scott H, Haraldsen G (2008)
Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation
Am J Pathol, 173 (4), 1229-42
PubMed 18787100